TSS
ARMP icon

Two Sigma Securities’s Armata Pharmaceuticals ARMP Stock Holding History

Two Sigma Securities’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,104
Closed -$24.9K – 1378
2025
Q2 		$24.9K Buy
+13,104
New +$21.2K ﹤0.01% 1178
2019
Q2 		– Sell
-3,581
Closed -$15K – 2063
2019
Q1 		$15K Buy
+3,581
New +$13.6K ﹤0.01% 1693
2017
Q4 		– Sell
-1,430
Closed -$18K – 1720
2017
Q3 		$18K Buy
+1,430
New +$18.3K ﹤0.01% 835

Other funds holding ARMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Securities's ARMP Position: Q3 2025 in Review

Two Sigma Securities sold out of Armata Pharmaceuticals (ARMP) in Q3 2025, closing a stake of 13,104 shares — an estimated $24.9K sold.

Two Sigma Securities first reported a position in ARMP in Q3 2017 and held it in 3 quarters. The position peaked at $24.9K in Q2 2025. 28 funds tracked by Wall St. Rank hold ARMP as of Q3 2025.

  • Two Sigma Securities reported no remaining Armata Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 13,104 Armata Pharmaceuticals shares in Q3 2025, an estimated $24.9K.
  • Two Sigma Securities first reported a position in Armata Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • Two Sigma Securities's Armata Pharmaceuticals position peaked at $24.9K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.